000 01629 a2200421 4500
005 20250515064128.0
264 0 _c20070817
008 200708s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.00831-06
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDurand-Gasselin, Lucie
245 0 0 _aEvidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cJun 2007
300 _a2105-11 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdenine
_xadministration & dosage
650 0 4 _aAnti-HIV Agents
_xadministration & dosage
650 0 4 _aDrug Interactions
650 0 4 _aDrug Therapy, Combination
650 0 4 _aErythrocytes
_xmetabolism
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aLamivudine
_xadministration & dosage
650 0 4 _aNucleosides
_xadministration & dosage
650 0 4 _aOrganophosphonates
_xadministration & dosage
650 0 4 _aPhosphorylation
650 0 4 _aReverse Transcriptase Inhibitors
_xadministration & dosage
650 0 4 _aTenofovir
650 0 4 _aTreatment Outcome
650 0 4 _aZidovudine
_xadministration & dosage
700 1 _aDa Silva, David
700 1 _aBenech, Henri
700 1 _aPruvost, Alain
700 1 _aGrassi, Jacques
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 51
_gno. 6
_gp. 2105-11
856 4 0 _uhttps://doi.org/10.1128/AAC.00831-06
_zAvailable from publisher's website
999 _c16988385
_d16988385